Comparison of Nasal Positive End Expiratory Pressure Valve to Dental Device as an Alternative Treatment for Obstructive Sleep Apnea
Not Applicable
Completed
- Conditions
- Obstructive Sleep ApneaAdverse Effects
- Interventions
- Device: nasal peep valve "Provent"
- Registration Number
- NCT01553383
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
Determine the clinical efficacy in terms of Apnea Hypopnea Index (AHI), excessive daytime sleepiness (EDS), nocturnal oxygenation of a nasal Positive end-expiratory pressure (PEEP) valve "Provent" in obstructive sleep apnea. The hypothesis is the efficacy will be better than dental device.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Symptomatic patients confirmed of OSA by sleep study (PSG according to AASM criteria or validated level 3 portable monitoring devices with AHI > 10/hr)
- Not using CPAP for any reasons or patients on dental device but would like to try alternative treatments for OSA.
- Able to sign informed consent and use the PEEP nasal valve.
- Age between 18-65 years old.
- Willing to attend follow up.
Read More
Exclusion Criteria
- Known nasal problems like deformities or significant rhinitis affecting application of PEEP nasal valve.
- Unable to sign consent or use PEEP nasal valve.
- Significant or unstable co-morbidities requiring other forms of treatment for OSA as priority.
- Coexisting sleep disordered breathing condition other than OSA requiring more complex treatment. E.g. central sleep apnea, significant Cheyne Stokes respiration or hypoventilation syndrome.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Dental device nasal peep valve "Provent" "Provent" nasal peep valve vs dental device CPAP nasal peep valve "Provent" continuous positive airway pressure "CPAP" vs nasap peep valve "Provent"
- Primary Outcome Measures
Name Time Method Apnea Hypopnea Index (AHI) 1 month
- Secondary Outcome Measures
Name Time Method side effects as a measure of tolerability 1 month
Trial Locations
- Locations (1)
Department of Medicine and Therapeutics, Prince of Wales Hospital, CUHK
ðŸ‡ðŸ‡°Shatin, Hong Kong